Harmful Drugs Law
What are the results of FDA’s safety review of Actos?
On January 31, 2011, the Food and Drug Administration placed Actos on its watchlist for further study into its side effects. On June 15, 2011 the FDA released a safety announcement informing the public that using Actos for more than one year may increase the risk of bladder cancer. On August 4, 2011 the FDA informed the public thorough a Safety Communication, that it approved an update to the drugs warning label. The purpose of the update was to warn doctors and patients of the increased risk of bladder cancer associated with taking Actos.